08:48 AM EDT, 09/20/2024 (MT Newswires) -- Health care stocks were mixed premarket Friday as the iShares Biotechnology ETF (IBB) was 0.2% higher and the Health Care Select Sector SPDR Fund (XLV) was recently down 0.1%.

Apellis Pharmaceuticals ( APLS ) shares fell past 7% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, reaffirmed its negative opinion on the firm's marketing authorization application for intravitreal pegcetacoplan to treat geographic atrophy.